Article
Inhibition of C5 or absence of C6 protects from sepsis mortality.
Immunobiology - 1 Jan 2004
Buras Jon A, Rice Lauren, Orlow Daniel, Pavlides Stavros, Reenstra Wende R, Ceonzo Kathleen, Stahl Gregory L
Abstract excerpt
Inhibiting complement anaphlytoxin C5a during sepsis may prevent sepsis mortality. Although human anti-C5 antibodies exist, their therapeutic use in microbial sepsis has been avoided because of the hypothesis that inhibiting C5b will prevent formation of the bactericidal membrane attack complex (MAC) and worsen clinical outcome. We wished to test the hypothesis that inhibition of C5 would improve outcomes in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
